[1]
DAS, P. and BORAH, M. 2026. EFFICACY OF PCSK9 INHIBITORS IN ADDITION TO BACKGROUND STATIN THERAPY COMPARED WITH PLACEBO IN ACHIEVING LDL-C TARGETS IN ADULTS WITH HYPERLIPIDAEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. International Journal of Current Pharmaceutical Research. 18, 1 (Jan. 2026), 23–29. DOI:https://doi.org/10.22159/ijcpr.2026v18i1.7091.